Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572221 · ClinicalTrials.gov registry record · NA
Improving the Quality of Care in Nursing Homes
A NA study, sponsored by Hebrew SeniorLife.
- Completed
- Registry status
- NA
- Development phase
- 4,316
- Enrollment target
NCT00572221: Completed NA study, sponsored by Hebrew SeniorLife.
NCT00572221 is a NA study that has completed, run by Hebrew SeniorLife. The registered enrollment target is 4,316 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (207% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00572221, a NA study, has completed, sponsored by Hebrew SeniorLife.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,316 participants
- Enrollment target
Study Summary
The overall goal of this project is to increase the number of high quality nursing homes in Massachusetts. The study will evaluate an intervention involving two active treatment arms: one implementing a CQI program and a second implementing the CQI program and specific protocol programming. The intervention will be implemented in 24 nursing homes identified as performing, over multiple quality indicator domains, at a poor or average level across multiple outcome domains.
Interventions
- BEHAVIORAL Continuing Quality Improvement and Quality Assurance system
- BEHAVIORAL CQI and QA System with Best-Practice Care Protocols
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,316 participants |
| Start Date | 2006-02 |
| Est. Completion | 2010-01 |
| Phase | NA |
What the finished NCT00572221 record still lists
NCT00572221 is an interventional study that assigns participants to a tested intervention. Its 4,316 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (207% higher).
The record links to 0 conditions, and to 2 interventions - of which Continuing Quality Improvement and Quality Assurance system is the first listed.
NCT00572221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00572221 about?
NCT00572221 is a clinical study titled "Improving the Quality of Care in Nursing Homes". The overall goal of this project is to increase the number of high quality nursing homes in Massachusetts. The study will evaluate an intervention involving two active treatment arms: one implementing a CQI program and a second implementing the CQI program and specific protocol programming. The inte...
What is the current status of trial NCT00572221?
This trial is currently completed. It is a NA study. The enrollment target is 4,316 participants. The study started on 2006-02. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00572221?
The interventions under investigation include: Continuing Quality Improvement and Quality Assurance system (BEHAVIORAL), CQI and QA System with Best-Practice Care Protocols (BEHAVIORAL).
Who is sponsoring clinical trial NCT00572221?
This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00572221's enrollment target sits among peer trials
4,316 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia